Navigation Links
Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules
Date:2/7/2008

PRINCETON, N.J., Feb. 7 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received tentative approval from the U.S. Food and Drug Administration for Esomeprazole Magnesium Delayed-Release Capsules, 20 mg (base) and 40 mg (base). Nexium(R) (Esomeprazole) is the second largest selling drug in the U.S. with total annual market sales of $5.5 billion (IMS -- MAT: December 2007).

Ranbaxy believes that it has a FTF (First to File) status on the drug, providing it with a potential 180 days marketing exclusivity, thereby offering a significant opportunity in the future.

Esomeprazole is indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis, to maintain symptom resolution and healing of erosive esophagitis and for treatment of heartburn and other symptoms associated with Gastroesophageal Reflux Disease (GERD).

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India's largest pharmaceutical company. RPI is engaged in the sale and distribution of generic and branded prescription products in the U.S. healthcare system.

Ranbaxy Laboratories Limited, headquartered in India, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy's continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. The Company's foray into Novel Drug Delivery Systems has led to proprietary "platform technologies", resulting in a number of products under development. The Company is serving its customers in over 125 countries and has an expanding international portfolio of affiliat
'/>"/>

SOURCE Ranbaxy Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
2. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
3. Halogen Receives High Ratings from Bersin & Associates - Company recognized as a market leader, and receives praise for outstanding customer satisfaction
4. Tryton Medical Receives CE Mark Approval for its Side-Branch Stent
5. AMDL Receives a Significant Updated Appraisal of Its JJB China Production Facilities
6. CuraGen Corporation Receives Notification from NASDAQ
7. Log-ic Temperature Sensor Receives EN12830 Certification
8. Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve
9. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
10. A Magnetic Gift: Sumter Regional Hospital Receives New MRI as Charitable Donation From Siemens
11. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...I, Nov. 30 /PRNewswire-Asia/ -- WuXi PharmaTech (N...gy, and medical-device research and,development ou... United States,announced that it had been selecte...st for the fifth consecutive year. The list recogn...echnology, media, and telecommunications,industrie...
(Date:11/29/2009)... in German . , The concept of confinement i...most famous example is that of quarks which bind t...lla Lake from Helmholtz-Zentrum Berlin together wi...the first time an experimental realization and a p...nsed matter system. , The concept of confinement...
(Date:11/27/2009)...ber 27 Stallergenes has ...) in both adults and children,through a Mutual Rec...re,Oralair(R) has been marketed, was the reference...ered in Austria, Belgium, Bulgaria, Cyprus, the,Cz...ngary, Ireland, Italy,Latvia, Lithuania, Luxembou...
(Date:11/25/2009)...C., Nov. 25 Research Triangle Park...ient, single-treatment water purification system N...hra Pradesh, Minister of Rural Water Supply, Hon. ...India today. Initial tests, performed at Indian In... the majority of the drinking water available in I...
Breaking Biology Technology:WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Spinons -- confined like quarks 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2
... Feb. 25 The International,Confocal Microscopy Wo...ssionals and students, has been formed as a means ...lective confocal microscopy (RCM) in,patient care....bers worldwide.,Dermatologists, dermascopists, der...ssionals interested in learning more about RCM sho...
...25 Barr Pharmaceuticals,Inc. (NYSE: BRL ) today ...cals, Inc., has received notification that the U.S...for review its New Drug Application,(NDA) for Lo S...lets 0.10,mg/0.02 mg and ethinyl estradiol tablets...ompany is seeking approval to manufacture and mark...
.... 25 Nile Therapeutics,Inc. (OTC Bulletin Board: ...eveloping therapies for cardiovascular disease, is...Lieu, M.D., F.A.C.C. as its Vice President of,Clin...eu to Nile. Dr. Lieu has extensive,cardiovascular ...mmediately,beneficial to Nile and our CD-NP and 2N...
Other Biology Technology:International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy 2Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA 2Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA 3Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA 4Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics 2Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics 3
(Date:11/26/2009)... MRSA (methicillin-resistant Staphylococcus Aure...annihilation as low-temperature plasma prototype d...asy and unfailing bactericidal cocktails. , Two ...icient disinfection of healthy skin (e.g. hands an...ria can pose a lethal threat; and another to shoot...
(Date:11/25/2009)... Athens, Ga. Bacteria don,t have easy lives. In ...the bugs, they have natural enemies called bacteri...rth every two days. , Still, bacteria and anoth...iscovered in extreme environments such as deep-sea...art because they have a built-in defense system th...
(Date:11/25/2009)... MADISON, WI, NOVEMBER 25, 2009 Soil is the linc...re, and hydrosphere meet. Despite that, many stude...s, but nothing more. Soil science educators are ch... public recognize the critical importance of soil ...y soil science and earth science teachers at Unive...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3It's not just dirt! 2Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of September 2009 13954 1Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of September 2009 13954 2Scientists Find Clue to Dangerous Side Effect of MS Drug 56673 1Scientists Find Clue to Dangerous Side Effect of MS Drug 56673 2Scientists Find Clue to Dangerous Side Effect of MS Drug 56673 3Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 1Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 2Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 3
...oking for a mate who in everyday conversation can ... a musician, Northwestern University researchers s...opean Journal of Neuroscience , an interdisciplina...rovides biological evidence that musical training ...ion in sound. , "Quickly and accurately identify...
... Park Zoo post-doctoral researcher Carson Murray, ...s from one of the world,s foremost medical researc...and her mentors, Elizabeth Lonsdorf, Ph.D. and Rac...a McClintock, Ph.D. of the University of Chicago w...panzees and discover how stress relates to materna...
...ch 3, 2009) When it comes to solving complex prob...and biomedical engineer, looks to nature for solut...n has produced, von Maltzahn is currently helping ...roving tumor detection and therapeutic delivery in...ts. , Today, the 28-year-old Ph.D. candidate in ...
Other Biology News:Musicians have biological advantage in identifying emotion in sound 2Musicians have biological advantage in identifying emotion in sound 3Lincoln Park Zoo scientists awarded National Institutes of Health grant 2MIT student develops new innovations to selectively kill cancer cells 2MIT student develops new innovations to selectively kill cancer cells 3MIT student develops new innovations to selectively kill cancer cells 4
Frozen Tissue Section Panel - Monkey (Cynomolgus) Normal Tissue, Multi-tissue I from BioChain
XRS Series Precision Linear Tables from Parker Hannifin Corporation
Goat Anti-UGT1A6 (D-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
... features T Squareds patented high efficiency dyna...ce and efficiency. With the most compact, lightwei...al for use in portable air and gas applications.,...fficiency. , Includes DC Motor. , Provides quiet ...
Biology Products: